WASHINGTON, D.C. 20549  





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):   June 20, 2019


            Creative Medical Technology Holdings, Inc.            

(Exact name of registrant as specified in its charter)


Nevada   000-53500   88-0622284
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
 of incorporation)       Identification Number)


          2017 W Peoria Avenue, Phoenix, AZ 85029          

(Address of principal executive offices)


          (602) 680-7439          

(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each class Ticker symbol(s) Name of each exchange on which registered

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  x


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨






Item 8.01. Other Events.


On June 20, 2019, Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), issued a press release to update shareholders on recent business activities.


The press release, furnished as Exhibit 99.1 to this Form 8-K, contains forward-looking statements. Such forward-looking statements are based on information presently available to the Company’s management and are current only as of the date made. Actual results could also differ materially from those anticipated as a result of a number of factors, including, but not limited to, those discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and subsequent reports filed by the Company with the Securities and Exchange Commission (the “Commission”). For those reasons, undue reliance should not be placed on any forward-looking statement. The Company assumes no duty or obligation to update or revise any forward-looking statement, although it may do so from time to time as management believes is warranted or as may be required by applicable securities law. Any such updates or revisions may be made by the registrant by filing reports with the Commission, through the issuance of press releases or by other methods of public disclosure. 


Item 9.01. Financial Statements and Exhibits.


(d)        Exhibits .


Exhibit 99.1 Press Release dated June 20, 2019







Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  Creative Medical Technology Holdings, Inc.
Date: June 24, 2019 By: /s/ Timothy Warbington
    Timothy Warbington, Chief Executive Officer




Creative Medical Technol... (PK) (USOTC:CELZ)
Historical Stock Chart
From Aug 2020 to Sep 2020 Click Here for more Creative Medical Technol... (PK) Charts.
Creative Medical Technol... (PK) (USOTC:CELZ)
Historical Stock Chart
From Sep 2019 to Sep 2020 Click Here for more Creative Medical Technol... (PK) Charts.